Gilmore Neil O'Neill's Net Worth

$6.26 Million

Estimate Recalculated Nov 7, 2024 05:13PM EST

Who is Gilmore Neil O'Neill

Gilmore Neil O'Neill has an estimated net worth of $6.26 Million. This is based on reported shares across multiple companies, which include Sarepta Therapeutics, Inc., Unity Biotechnology, Inc., Aptinyx Inc., and Editas Medicine, Inc..

SEC CIK

Gilmore Neil O'Neill's CIK is 0001742084

Past Insider Trading and Trends

2021 was Gilmore Neil O'Neill's most active year for acquiring shares with 5 total transactions. Gilmore Neil O'Neill's most active month to acquire stocks was the month of February. 2024 was Gilmore Neil O'Neill's most active year for disposing of shares, totalling 3 transactions. Gilmore Neil O'Neill's most active month to dispose stocks was the month of April. 2022 saw Gilmore Neil O'Neill paying a total of $0.00 for 1,101,864 shares, this is the most they've acquired in one year. In 2024 Gilmore Neil O'Neill cashed out on 91,570 shares for a total of $805,206.44, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sarepta Therapeutics, Inc.

EVP, R&D & CMO
Updated Mar 10, 2021
Form 4/A
102.89%
14.48K
$86.97
-$45.57K
Mar 10, 2021
28.55K
Grant
Feb 28 - Mar 03
Form 4
533.05%
75.00K
Mar 05, 2021
89.07K
Grant
Mar 03
Form 4
599.73%
44.20K
Feb 28, 2020
51.57K
Grant
Feb 28
Form 4
-38.58%
-4.63K
$119.31
-$552.41K
May 24, 2019
7.37K
Options
May 23 - May 24
Form 4
55.00K
Mar 04, 2019
55.00K
Grant
Mar 04
Form 4
112.00K
Jun 11, 2018
112.00K
Grant
Jun 07
Form 3
Jun 11, 2018
Showing 7 results

Unity Biotechnology, Inc.

Investor
Updated Jun 21, 2024
Form 4
10.00K
Jun 21, 2024
10.00K
Grant
Jun 21
Form 4
6.00K
Jun 26, 2023
6.00K
Grant
Jun 23
Form 4
25.00K
Jun 27, 2022
25.00K
Grant
Jun 24
Form 4
13.43K
Jun 28, 2021
13.43K
Grant
Jun 24
Form 4
50.00K
Dec 14, 2020
50.00K
Grant
Dec 10
Form 3
Dec 14, 2020
Showing 6 results

Aptinyx Inc.

Investor
Updated May 31, 2022
Form 4
40.00K
May 31, 2022
40.00K
Grant
May 26
Form 4
80.00K
Oct 22, 2021
80.00K
Grant
Oct 19
Form 3
Oct 22, 2021
Showing 3 results

Editas Medicine, Inc.

CEO
Updated Sep 06, 2024
Form 4
-0.49%
-1.55K
$3.42
-$5.33K
Sep 06, 2024
313.72K
Sale
ScheduledSep 04
Form 4
-3.72%
-12.19K
$5.50
-$67.00K
Jun 06, 2024
315.28K
Sale
ScheduledJun 04
Form 4
452.80%
589.40K
$9.42
-$732.88K
Mar 05, 2024
719.57K
Grant
ScheduledMar 02 - Mar 05
Form 4
-4.75%
-6.49K
$9.50
-$61.64K
Jun 07, 2023
130.17K
Sale
Jun 05
Form 4
230.80%
200.00K
Mar 06, 2023
286.66K
Grant
Mar 02
Form 4
1.04M
Jun 06, 2022
1.04M
Grant
Jun 02
Form 3
Jun 06, 2022
Showing 7 results